Resource Library

Stakeholder conversations to inform delivery of new HIV prevention methods in Zimbabwe

Little is known about what is needed for health care providers to ensure adequate counseling on method choice, referral mechanisms, and supportive follow-up with regards to multiple biomedical HIV prevention methods. The goal of these conversations with stakeholders in Zimbabwe was to gain input on implementation considerations from provider and potential end-user perspectives, as well…

Eswatini Dapivirine Ring Consultation Analysis

This PrEP ring consultation analysis can support introduction of the dapivirine vaginal ring in Eswatini and is based on several inputs, including secondary research and interviews with key stakeholders in Eswatini.

Modelling Impact of Injectable Cabotegravir for PrEP on Drug Resistance

An important consideration in the scale-up of injectable cabotegravir (CAB) for PrEP is the potential for development of Integrase Strand Transfer Inhibitor (INSTI) resistance. To help stakeholders understand this issue further, Professor Andrew Phillips from University College London shared the results of an exercise modelling the impact of the introduction of CAB for PrEP on…

Financing & Costing, Testing

Step by Step Oral PrEP Liberia Guidelines, 2021

This national guide adapts WHO guidelines on oral PrEP to Liberia's local context.

Normative Guidance/Policies

Product Introduction/Implementation Project Planning for Next-Generation PrEP

Early data from clinical trials has indicated that Cabotegravir (CAB) for PrEP is safe and effective. With an accelerated timeline for introduction of CAB for PrEP, AVAC and WHO convened a think tank to strategize about demonstration projects and other planning for product introduction.

HIV Testing and Injectable Cabotegravir (CAB for PrEP) Introduction: What are the implications for HIV prevention scale-up and the HIV response?

One challenge which has emerged with the introduction of CAB for PrEP is the risk of Integrase Strand Transfer Inhibitor (INSTI) resistance amongst people who acquire HIV while taking CAB as prescribed. To address emerging evidence around testing algorithms and INSTI resistance in CAB users, AVAC and WHO convened a think tank with program implementers,…

Testing

Stakeholder conversations to inform delivery of multiple HIV prevention methods in Kenya

This report highlights findings from stakeholder conversations implemented in Kenya as part of the PROMISE Collaboration to gain input on implementation considerations for the introduction of the PrEP ring alongside oral PrEP and future inclusion of additional prevention methods for women

Research, Service Delivery

Prevention Options for Women Evaluation Research (POWER) Formative Work Report – August 2017

This is a formative work report on the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Prevention Options for Women Evaluation Research Key Informant Interviews Qualitative Report – July 2020

This is a report on Key Informant Interviews undertaken for the POWER Study, which aimed to characterize choice, uptake, and early adherence to PrEP, and sought to identify cost-effective and scalable delivery models to young women in Kenya and South Africa.

Research

Digital Health Landscaping Report

This landscape analysis aimed to identify common virtual channels used in several countries, estimate the number of users of each channel, and categorize countries into one of three groups based on potential for interventions to use virtual channels to succeed. Users were defined as adolescent girls and young women (aged 15–24), pregnant or breastfeeding people…

Demand Creation/Marketing, Service Delivery